Abel Hall »

Takeda Pharmaceutical shares owned by Abel Hall

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Abel Hall from 13F filings

Historical chart of Abel Hall investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Abel Hall consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Abel Hall

Quarter filed Position value Share count Share price at filing
2025-12-31 $519k 33k 15.59

More positions owned by Abel Hall

Dimensional Etf Trust Us Core Equity 2 (DFAC)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dimensional Etf Trust Intl Small Cap V (DISV)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Abel Hall

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
FMR
UBS Group
Brandes Investment Partners
Toronto-Dominion Bank
BlackRock
Millennium Management
Renaissance Technologies
First Trust Advisors
Van Eck Associates Corp.
Northern Trust
Citadel Advisors
Managed Asset Portfolios

View all funds holding Takeda Pharmaceutical